Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS‐13
Marie Scully(University College Hospital), Samuel J. Machin(University College London), Sylvia Benjamin(Oxford University Hospitals NHS Trust), Hannah Cohen(University College London Hospitals NHS Foundation Trust), Sally Killick(Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust), Richard Starke(University College London), Jamie Cavenagh(St Bartholomew's Hospital), Ian Mackie(University College London)
Cited by 267
Related Papers
IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response
|Science|2007|1.4k
The “Primary” Antiphospholipid Syndrome
|Medicine|1989|963
Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies
|British Journal of Haematology|2012|861
Guidelines for the diagnosis and management of adult aplastic anaemia
|British Journal of Haematology|2015|750